Pura Vida Investments’s Senti Biosciences Holdings SNTI Stock Holding History

Pura Vida Investments’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,570	Closed	-$2.54M	–	302
2021 Q3	$2.54M	Buy	25,570 +570	+2%	+$56.2K	0.08%	179
2021 Q2	$2.48M	Buy	+25,000	New	+$2.49M	0.08%	146

Other funds holding SNTI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Pura Vida Investments's SNTI Position: Q4 2021 in Review

Pura Vida Investments sold out of Senti Biosciences Holdings (SNTI) in Q4 2021, closing a stake of 25,570 shares — an estimated $2.54M sold.

Pura Vida Investments first reported a position in SNTI in Q2 2021 and held it in 2 quarters. The position peaked at $2.54M in Q3 2021. 42 funds tracked by Wall St. Rank hold SNTI as of Q4 2021.

Pura Vida Investments reported no remaining Senti Biosciences Holdings position as of Q4 2021 after selling out during the quarter.
Pura Vida Investments sold 25,570 Senti Biosciences Holdings shares in Q4 2021, an estimated $2.54M.
Pura Vida Investments first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 2 quarters.
Pura Vida Investments's Senti Biosciences Holdings position peaked at $2.54M in Q3 2021.
42 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.